Beckman Coulter Inc.: Device Recall

Recall #Z-0673-2025 · 11/08/2024

Class II: Risk

Recall Details

Recall Number
Z-0673-2025
Classification
Class II
Product Type
Device
Recalling Firm
Beckman Coulter Inc.
Status
Ongoing
Date Initiated
11/08/2024
Location
Brea, CA, United States
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
31 US; 167 OUS

Reason for Recall

The reason for the recall is that EDTA and lithium heparin plasma samples that are stored in the DxI 9000 Access Immunoassay Analyzer sample wheel for a prolonged period before performing the intact PTH (parathyroid hormone) test may produce falsely decreased intact parathyroid hormone results. This could lead to a missed diagnosis, a delay in treatment, or inappropriate clinical management, depending upon the patient s clinical condition.

Product Description

Access Intact PTH assay on the DxI 9000 Access Immunoassay Analyzer, Catalog number A16972, for the quantitative determination of intact parathyroid hormone (parathyrin, PTH) levels in human serum and plasma.

Distribution Pattern

Foreign distribution to Albania, Australia, Austria, Bahrain, Belgium, Brazil, C¿te d'Ivoire, Croatia, Czechia, Egypt, France, Germany, Ghana, Hungary, India, Ireland, Israel, Italy, Kazakhstan, Kuwait, Malaysia, Netherlands, New Zealand, Poland, Portugal, Slovakia, South Africa, S. Korea, Spain, Switzerland, Taiwan, United Kingdom of Great Britain and Northern Ireland.

Other Recalls by Beckman Coulter Inc.

View all recalls by Beckman Coulter Inc. →

Data from FDA openFDA enforcement reports. This site is not affiliated with or endorsed by the FDA. Recall information may be updated by the FDA at any time.